Fig. 1From: Risk factors for interstitial lung disease induced by gemcitabine plus albumin-bound paclitaxel therapy in pancreatic ductal adenocarcinoma patientsFrequency and grade of interstitial lung disease in patients receiving gemcitabine plus albumin-bound paclitaxel therapy in this studyBack to article page